OptimizeRx Corporation (OPRX)

Market Cap	287.07M
Revenue (ttm)	109.51M
Net Income (ttm)	34,000
Shares Out	18.64M
EPS (ttm)	0.00
PE Ratio	8,318.82
Forward PE	21.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	202,892
Open	15.23
Previous Close	15.29
Day's Range	15.16 - 15.59
52-Week Range	3.99 - 22.25
Beta	1.08
Analysts	Buy
Price Target	14.83 (-3.7%)
Earnings Date	Nov 6, 2025

About OPRX

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2006
• Employees: 129
• Stock Exchange: NASDAQ
• Ticker Symbol: OPRX
• Website: https://www.optimizerx.com

Financial Performance

In 2024, OptimizeRx's revenue was $92.13 million, an increase of 28.81% compared to the previous year's $71.52 million. Losses were -$20.11 million, 14.5% more than in 2023.

Analyst Summary

According to 6 analysts, the average rating for OPRX stock is "Buy." The 12-month stock price target is $14.83, which is a decrease of -3.70% from the latest price.

Price Target

$14.83

(-3.70% downside)

Analyst Consensus: Buy